thescrippsresearchinstitute

  • An Experimental HIV Vaccine Shows Promise in Early Human Trial

    An Experimental HIV Vaccine Shows Promise in Early Human Trial

    An experimental HIV vaccine appears to have passed its first test in humans. In a newly released study, the vaccine candidate produced the sort of immune response that scientists had been hoping for in 97% of recipients. Importantly, the vaccine also seemed to be safe and well-tolerated.